Get notified when COO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Litigation Expense (new) — A new $272M net litigation charge related to the recalled embryo culture media was recorded, with over 140 lawsuits and 1,500 claimants.
- Working Capital Decline (worsened) — Working capital fell from $1,127.7M to $414.9M year-over-year, primarily due to increased short-term debt.
- UK Payroll Tax Dispute (new) — A UK First-tier Tribunal decision largely supported HMRC in a payroll tax dispute, with potential loss up to £71.7M plus interest.
revenue $1.07B, net income $432.8M. Cooper Companies' Q3 net income soars 340% on tax benefit; litigation charge weighs
Filed September 9, 2026 · Period ending July 31, 2026 · Compared to 10-Q Aug 28, 2025 · ~1 min read
Key Changes
-
high
Net income jumped 340.3% to $432.8M, driven by a $307.2M discrete tax benefit from a favorable UK tax examination, not operations.
MD&A: Tax verify on EDGAR → -
high
Working capital fell to $414.9M, primarily due to higher short-term debt.
MD&A: Liquidity verify on EDGAR → -
medium
Board approved a $1B increase to the buyback program in September 2026, raising total authorization to $3B with ~$1.5B remaining.
Subsequent Events view on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.
Partner
Trade COO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 9, 2026 · How we verify